Medical technology company making orthopaedic implants and robotic-assisted surgery systems for joint replacement.
OMNI life science, Inc. develops orthopaedic technologies, including the Apollo platform and ApolloKnee software, which support robotic and AI-assisted joint replacement surgery. Founded in 1999 in the United States, it sells mainly to hospitals and surgical centers in markets such as the United States, Europe and Australia. In April 2014 the company raised USD 27.5 mn in a Venture Debt round led by Deerfield Management, and it has completed three deals in total. Recorded stage: Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in